Adobe shares tumbled sharply in afternoon trading as a wave of investor concern over AI's competitive threat triggered a sector-wide sell-off, extending the software giant's recent slump.
ServiceNow led a sharp decline across major technology stocks as investor fears over AI-driven market disruption sparked a sector-wide retreat, highlighting the fragile sentiment in high-growth segments.
A new analysis from Goldman Sachs underscores how the high cost of homeownership in areas with top-tier public schools creates a dual barrier to wealth building and educational access for many American families.
Costco Wholesale's shares have delivered stellar multi-year returns, but a deep dive into valuation metrics suggests investors may now be paying a premium. With a P/E ratio far exceeding industry norms and a discounted cash flow model pointing to overvaluation, we examine whether the stock's price has run ahead of its fundamentals.
Meta Platforms' latest earnings reveal a staggering $115-135 billion AI infrastructure investment plan for 2026, alongside a $36.57 billion stock shelf registration. The move intensifies the debate on whether massive spending will fortify its ad empire or strain its financials amid growing regulatory pressures.
Energizer Holdings (ENR) shares have rebounded over 12% in the past month, yet remain down sharply over longer horizons. A detailed analysis of its cash flows and valuation multiples suggests the battery and household products maker may be trading at a significant discount to its intrinsic value.
Unity Software shares suffered their worst day in nearly two years following Google's unveiling of Project Genie, an AI world-building tool. While fears of disruption spooked investors, analysts and the company's CEO argue the selloff may have been an overreaction, highlighting fundamental differences between experimental AI and production-ready game development.
Experience management platform Qualtrics names former Oracle and NetSuite executive Jason Maynard as its new chief executive, aiming to accelerate AI adoption and drive growth in the evolving customer and employee experience landscape.
As the broader TSX enjoys a robust earnings season, a segment of smaller-cap companies is capturing attention for their high-risk, high-reward potential. We examine three such ventures—spanning cannabis, functional mushrooms, and AI diagnostics—that are on the radar of growth-oriented investors.
Crypto.com has launched a prediction market platform that, for the first time, allows retail users to trade on margin—a high-risk feature common in finance but unprecedented in regulated event betting.
As a key 2026 priority, the Financial Services Institute is pressing regulators for a contractor classification rule that protects the independent advisor model, while also targeting broader legislative and enforcement reforms.
Pfizer navigates a year of transition as declining COVID product sales and looming patent cliffs pressure revenue. The pharmaceutical giant is betting its future on a revitalized R&D strategy and newly acquired obesity assets from Metsera to drive growth beyond 2026.
In one of his last interviews, the late Berkshire Hathaway vice-chairman distilled a lifetime of investing wisdom: getting rich only has to happen once, but the initial climb is the most arduous. We explore the strategies to master that crucial first step.
Amidst market jitters, Nvidia CEO Jensen Huang argues the AI boom is built on a fundamental technological shift, not speculation. A closer look at valuations and profitability suggests this rally differs starkly from the dot-com era.
Spain announces a landmark ban on social media access for children under 16, coupled with stringent new measures to hold platforms and executives legally accountable for harmful content.
In a strategic expansion beyond stablecoins, Tether has unveiled an open-source operating system for Bitcoin mining. The move challenges the dominance of proprietary software giants and arrives as the mining industry navigates a complex landscape of compressed margins and intense competition.
Following its high-stakes rebrand from Yandex N.V., Nebius Group (NBIS) is betting its future on full-stack AI infrastructure. Despite a dramatic 164% one-year shareholder return, recent volatility and a steep pullback have investors questioning if the stock's sell-off presents a buying opportunity or signals deeper challenges.
As Valentine's Day approaches, cybersecurity experts issue urgent warnings about sophisticated online romance scams. These schemes, which use emotional manipulation and sometimes AI, have led to devastating financial losses for victims seeking connection.
While Merck (MSD) delivered robust fourth-quarter results, its forecast for 2026 fell below Wall Street expectations, highlighting investor anxiety over impending patent expiries for blockbuster drugs like Keytruda.
Despite a stellar year-to-date performance fueled by promising clinical trial results, analyst sentiment on Moderna remains tempered, with a consensus 'Hold' rating highlighting the challenges beyond its COVID-19 windfall.
